What Is LipiSperse® Absorption Technology?
Not all nutrients are easy for the body to absorb. Some nutrients can be harder to disperse in water, which may affect how evenly they are delivered in the digestive system.
At FutureLab, we use LipiSperse® technology to help solve this problem. A delivery system designed to help nutrients disperse more evenly in the digestive system, which may support absorption.
Features
Helps Nutrients Mix Better
LipiSperse® breaks ingredients into tiny particles, helping them spread evenly instead of clumping together.
Supports Absorption
Better dispersion supports the way nutrients are taken up in the digestive system.
Smaller, Smarter Formulas
Formulated with dispersion technology to help reduce undissolved material. Because absorption is optimised, they are designed to fit easily into your daily routine and formulated with convenience.
Benefits
Easy-To-Take Products
Capsules designed for everyday use, fitting easily into your daily routine.
Efficient Delivery
LipiSperse® is designed to help nutrients disperse more evenly in the digestive system.
- LipiSperse® technology is one of the ways FutureLab sets itself apart.
- LipiSperse® helps nutrients work smarter, not harder.
Explore Best Sellers
References
Luo L, He Y, Zhu L, Sun D, Chen C, Liu S, et al. Effects of LipiSperse® delivery system on the bioavailability of curcumin: a randomized, double-blind, crossover study. Nutrients. 2018;10(3):E285. doi:10.3390/nu10030285.
Mah E, Sapper TN, Chitchumroonchokchai C, Failla ML, Schill KE, Clinton SK, et al. Enhancement of carotenoid bioavailability from mixed carotenoid micelles using a novel delivery system (LipiSperse®). Mol Nutr Food Res. 2019;63(19):1900445. doi:10.1002/mnfr.201900445.
Zou L, Peng S, Liu W, Gan L, Liu C, Liang R, et al. Improved dispersibility and bioaccessibility of resveratrol using a novel LipiSperse® delivery technology. Food Funct. 2020;11(4):3452-3462. doi:10.1039/d0fo00076k.
Singh A, Rao A, Ahn-Jarvis J, Sudakaran D, Gopinath A. Enhanced dispersion and absorption of quercetin with LipiSperse® technology: results from a human pilot trial. Phytother Res. 2021;35(7):3881-3890. doi:10.1002/ptr.7042.
Pharmako Biotechnologies. LipiSperse® Technology: White paper. Sydney: Pharmako Biotechnologies Pty Ltd; 2022. Available from: https://pharmako.com.au/lipisperse